What is it about?
This was a prospective, pharmaceutical, FDA trial on the use of rocuronium in the pediatric patient population. Organon received a pediatric indication from the FDA because of this trial
Featured Image
Why is it important?
Rocuronium is not approved for use in pediatric patients.
Perspectives
A useful contribution to the literature.
Dr. Christopher F Tirotta
Nicklaus Children's Hospital
Read the Original
This page is a summary of: Time Course of Rocuronium-Induced Neuromuscular Blockade in Pediatric Patients: A Phase III, Randomized, Dose-Response Study, Journal of Anesthesia & Clinical Research, January 2012, OMICS Publishing Group,
DOI: 10.4172/2155-6148.1000189.
You can read the full text:
Contributors
The following have contributed to this page
